Management of Advanced Gastroenteropancreatic Neuroendocrine Tumors

Neuroendocrine neoplasms (NENs) comprise a diverse group of tumors that can arise throughout the body, making classification and treatment particularly complex. The NCCN Guidelines for Neuroendocrine and Adrenal Tumors have expanded to include treatment options based on the location, stage, and grade of the tumor, However, these treatment approaches rely on accurate pathologic classification of the tumor and correlation with imaging and clinical features. With a growing list of available systemic treatment options for advanced tumors and a disease continuum often measured in years, if not decades in some patients, treatment sequencing, quality of life, and potential long-term side effects remain important considerations.

Authors

Publication Details

Journal
Journal of the National Comprehensive Cancer Network
Published
2025-05-01
DOI
https://doi.org/10.6004/jnccn.2025.5012
Citations
2
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
2.71

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Management of Advanced Gastroenteropancreatic Neuroendocrine Tumors

Emily K. Bergsland
2 citations
Journal of the National Comprehensive Cancer Network
Neuroendocrine Tumor Research Advances
2.71
article

Management of Advanced Gastroenteropancreatic Neuroendocrine Tumors

Emily K. Bergsland
article en
2 citations

Abstract

Neuroendocrine neoplasms (NENs) comprise a diverse group of tumors that can arise throughout the body, making classification and treatment particularly complex. The NCCN Guidelines for Neuroendocrine and Adrenal Tumors have expanded to include treatment options based on the location, stage, and grade of the tumor, However, these treatment approaches rely on accurate pathologic classification of the tumor and correlation with imaging and clinical features. With a growing list of available systemic treatment options for advanced tumors and a disease continuum often measured in years, if not decades in some patients, treatment sequencing, quality of life, and potential long-term side effects remain important considerations.

Journal of the National Comprehensive Cancer NetworkVol. 23(Supplement)
University of California, San Francisco
Openalex Percentile: Top 10%
Neuroendocrine Tumor Research Advances
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.